Filing Details
- Accession Number:
- 0001562180-21-007868
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-22 21:51:47
- Reporting Period:
- 2021-12-20
- Accepted Time:
- 2021-12-22 21:51:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1689813 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1878290 | C. George Clark | C/O Biohaven Pharmaceuticals, Inc. 215 Church Street New Haven CT 06510 | Vp, Chief Accounting Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Disposition | 2021-12-20 | 1,915 | $123.84 | 8,240 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This sale was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.